19^th International Conference on Dementia and Dementia Care September 08-09, 2023 London, UK

Dr. Athanasios K. Petridis is an Associate Professor of the Department of Neurosurgery in University of Schleswig Holstein, Germany. He is also a Co-Director of the Spine Fellowship Program of AO Spine. He completed his Postdoc in the field of CNS-Regeneration from Memorial Sloan Kettering Cancer Center (MSKCC), New York. Dr. Petridis research interest is CNS-Regeneration, Stem cell regeneration and neurosurgical papers.

Dr. Petridis research interest is CNS-Regeneration, Stem cell regeneration and neurosurgical papers.

Dr. Muramatsu is currently a Professor of Neurology at Jichi Medical University (JMU) in Japan. He received his MD and PhD from JMU. He completed his neurology residency at both Gunma University and JMU. He was a visiting associate at National Institutes of Health in USA from1995 to 1997. He received the Award for Excellent Research (2001) and the TAKARA Bio Award (2011) from the Japan Society of Gene Therapy. Hisresearch group has been developing gene therapies for treating neurodegenerative diseases including Parkinson’s disease (PD), Alzheimer’s disease, and amyotrophic lateral sclerosis using adeno-associated virus (AAV) vectors. Dr. Muramatsu’s expertise has contributed to a clinical trial of gene therapy for aromatic L-amino acid decarboxylase deficiency in Taiwan.

Gene therapy, Movement disorders, Neurodegenerative diseases

Prof. Calabrese obtained his PhD in Psychology and a medical habilitation degree in experimental neurology (MDhabil) and medical neuropsychology at the University of Bochum (Germany). He has received his undergraduate degree in Psychology and Biology at the University of Konstanz (Germany) as well as preclinical medicine at the University of Zurich (Switzerland). He is also trained in cognitive behavioural therapy (CBT) and holds an european diploma in preventive medicine. In 1995 Dr. Calabrese was nominated as head of Department of Neuropsychology and Behavioral Neurology and head of the memory clinic at the University Hospital of Bochum (Germany). Since 2011

Prof. Calabrese research focus is in the field of diagnosis and treatmentof neuropsychological and behavioral disturbances in neuropsychiatric patients (with a focus on PD, AD and MS). He is involved in the conceptualization of several clinical trails in the field of behavioral neurology and psychiatry.

Dr. Kieran C. Breen is a Director of Research and Innovation at Parkinsons UK. He completed his Ph.D in Pharmacology/Neuroscience at University College, Dublin in 1987. Dr. Breen was a Director of Alzeimers Disease Research Centre in University of Dundee in 2005.

Development and implementation of the cure-focussed multidisciplinary research strategy at Parkinson's disease

etsumori Yamashima MD, PhD is a consultant neurosurgeon specialized in neuroscience. In 1975, he graduated from Kanazawa University Faculty of Medicine. In 1979, he completed his research diploma in the Kanazawa University Graduate School Medical Research Course (Doctor of Medicine). He then studied abroad in Germany and Sweden, including neuropathology and brain science. He became Chief of Medical Staff at Kanazawa University Hospital, Associate Professor of Kanazawa University Medical Faculty, and Director of Restorative Neurosurgery at Kanazawa University Graduate School of Medical Science. At present, he is CEO of the Arimatsu Medical and Dental Clinic in Kanazawa city, works at this clinic (Tuesday to Saturday), and at Minami-gaoka Hospital (consultant neurosurgeon: Monday mornings). At Kanazawa University Hospital (part-time lecturer: Monday afternoons), he heads a special “higher brain dysfunction” outpatient clinic. He is acknowledged for using the RBANS (Repeatable Battery for the Assessment of Neuropsychological Status), MRI and PET scans for early detection of Alzheimer’s disease, even a few years before dementia appears, allowing preventive treatment to be carried out. In 1998,

Alzheimer’s disease, Dementia

Dr. Hiroshi Nakanishi is currently a Professor of Departmet of Aging Science and Pharmacology, Faculty of Dental Science, Kyushu University. He completed his PhD in Pharmacology, Faculty of Pharmaceutical Sciences, Kyushu University and his post-doctoral training at Department of Anatomy and Neurobiology, the University of Tennessee at Memphis. He became an Associate Professor at Department of Pharmacology in 1999, and a Professor of Laboratory of Oral Aging Science, Faculty of Dental Science, Kyushu University in 2000. He was the Dean of Faculty of Dental Science, Kyushu University from 2011 to 2013. His reserach is focusing on the physiological and pathological functions of microglia in the central nervous system.

Dr. Nakanishi’s research interest includes: (1) Roles of microglia in the synaptic plasticity and synaptic reorganization, (2) Roles of microglia in the brain aging, (3) Rols of microglia in the chronic pain, (4) Roles of microglia in Neuropshychiatic disorders including autism

Dr. Kenneth M. Heilman received his M.D. degree from the University of Virginia in 1963. He was a PGY 1&2 in internal medicine at Cornell University Medical Center-Bellevue Hospital (1963-65). During the Vietnam War he joined the Air Force and was Chief of Medicine at NATO Hospital, Izmir, Turkey (1965-1967). After his service, he took a Neurology residency and fellowship at the Harvard Neurological Unit of Boston City (1967-1970), first with Dr. Denny-Brown and then with Dr. Norman Geschwind. In 1970 he joined the faculty at the University of Florida as an Assistant Professor, was promoted to Associate Professor in 1973 and Professor in 1975. He received the James E Rooks, Jr. endowed professorship in 1990 and in 1998 was promoted to a Distinguished Professor. In 1977

arch is neurobehavioral, examining brain behavior relationships in health and disease. He is the author or co-author or editor or co-editor of 14 published or ‘in press’ books and more than 500 peer reviewed publications.

Dr. Keiko Ikemoto is a Principal Director, Department of Psychiatry, Iwaki Kyoritsu General Hospital, Fukushima, Japan. She is a Visiting Professor in Tokushima Graduate University Keiko Ikemoto graduated Shiga University of Medical Science in 1985, specialized in Psychiatry (Prof. Saburo Takahashi) and Neuroscience (Prof Toshihiro Maeda), and then graduated the Graduate School of Shiga University of Medical Science in 1996, when finished PhD. She studied monoamine neuronal system and sleep as a Boursiere du Gouvernement Francais in the Department of Experimental Medicine, Claude Bernard University (Prof. Michel Jouvet) in France (1995-1996),

Neuroscience & Neuropsychiatry

Dr. Pappolla is currently a Professor appointment with the Department of Neurology at the University of Texas Medical Branch in Galveston . Dr. Pappolla received his MD degree from the University of Buenos Aires in Argentina in 1978. His training includes a PhD Doctorate in Human aging in Barcelona, Spain and medical residencies and fellowships in the USA in Neurology, Anatomic Pathology, Neuropathology and Interventional Pain Medicine (Anesthesia based). This training required 10 additional years of post graduate medical education, all pursued in programs accredited by the American Board of Medical Specialties.

Dr. Pappolla's research interest is in the development of treatments for neurological degenerative diseases. He has patented and developed novel neuroprotective agents such as OX-1 (now on phase 2 trial for Friedriech ataxia) and melatonin related analogs for Alzheimer's disease.

r. Roger J. Pomerantz received his B.A. and M.D. at the Johns Hopkins. He completed his Medicine internship and residency training, and his subspecialty clinical and research training in Infectious Diseases and Virology at the Massachusetts General Hospital of the Harvard Medical School, and served as the Chief Medical Resident at. His post-doctoral research training in Molecular Retrovirology was obtained at the Whitehead Institute of MIT. He was an endowed, tenured Professor of Medicine, Biochemistry and Molecular Pharmacology, Chief of Infectious Diseases, at the Thomas Jefferson University. Dr. Pomerantz joined Johnson & Johnson,

Neurovirology and Viral Latency, Virology